Trials / Completed
CompletedNCT01556087
Distress Tolerance and Buprenorphine
Distress Tolerance and Reducing Early Relapse in Buprenorphine Patients
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 59 (actual)
- Sponsor
- Butler Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The investigators propose that inability to tolerate the distress of opioid withdrawal and the negative affect associated with early abstinence are key factors in early illicit opioid lapse and subsequent buprenorphine treatment drop-out. Our intervention aimed at increasing distress tolerance is designed to increase treatment adherence.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Distress Tolerance | 7 individual sessions aimed at increasing distress tolerance skills |
| BEHAVIORAL | Health Education | 7 individual sessions with didactic health education information |
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2014-02-01
- Completion
- 2015-08-01
- First posted
- 2012-03-16
- Last updated
- 2015-09-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01556087. Inclusion in this directory is not an endorsement.